Amazon
youtube
A delay in a drug is a delay in someone's life. A delay in a medical device is a delay in someone's ability to interact with the world.
In this episode of Napkin to MVP, Ketryx's CEO and founder, Erez Kaminski, shares how an idea sketched at the end of 2019 in Cambridge, Massachusetts (accelerating regulated product development to the speed of regular software) became a platform now reaching millions of patients. From reading tens of thousands of pages of regulation as an MIT grad student, to a two-year build, to a top-five medical device company buying in almost on the spot, this is the unpolished story of going from napkin to MVP.
Building in a highly regulated industry means the infrastructure underneath has to be trustworthy by default. Ketryx built on AWS because its quality system is purpose-built for regulated, safety-critical use cases, freeing the team to move fast on the hard problem: turning 500,000 pages of compliance evidence into something automated, audit-grade, and 90% faster.
This is what building with AI on AWS looks like for startups: taking work that used to take a months or longer and now reaching patients today. AWS gives founders the AI, compute, and secure, compliant foundation to go from idea to impact faster.
Learn more about how Ketryx is building on AWS:
Explore AI for Startups:
Napkin to MVP is a founder-led series from AWS Startups showcasing how early-stage teams build from a first idea to a real product with AI on AWS. Subscribe for more
|
2026/10/12
youtube
